Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Fresenius Medical Care Q4 Adjusted EPADS $0.47 Beats $0.32 Estimate, Sales $5.37B Beat $5.35B Estimate

Author: Benzinga Newsdesk | February 20, 2024 05:57am
Fresenius Medical Care (NYSE:FMS) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.32 by 48.12 percent. This is a 7.73 percent increase over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $5.37 billion which beat the analyst consensus estimate of $5.35 billion by 0.36 percent. This is a 5.28 percent increase over sales of $5.10 billion the same period last year.

Posted In: FMS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist